Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
18th Bioshares Biotech Summit
Summit History
Contact
Contact Us
Email Alerts
Home
>
Special Features
Special Features
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
2017
2016
2014
2013
2012
2011
2010
2009
2008
2007
2006
18-May-2012
Edition 455 - Multiple Value Drivers Support Interest in Mesoblast’s Share Price
11-May-2012
Edition 454 - Mayne Pharma Group - Life After Doryx?
4-May-2012
Edition 453 - Tissue Therapies – Approval & Product Launch Approaching
27-Apr-2012
Edition 452 - Biota Plans Merger with Nasdaq-listed Nabi Biopharmaceuticals and ASX De-listing
20-Apr-2012
Edition 451 - Pharmaxis – Bronchitol Ready to Go!
14-Apr-2012
Edition 450 - Sirtex Sales Boom in the US
30-Mar-2012
Edition 449 - Quarterly Review - Investors Favour Biotech
23-Mar-2012
Edition 448 - Australian Biotechs Continue Charge To Market With Late Stage Clinical Assets
16-Mar-2012
Edition 447 - QRxPharma – Ability to Succesfully Launch Novel Pain Drug Now Clearly Visible
9-Mar-2012
Edition 446 - IPO Profile - Osprey Medical Inc
Previous
1
2
3
4
5
Next